(Q39939391)

15 September 2017

title

Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study (English)

1 reference

15 September 2017

1 reference

coronary artery disease

1 reference

J Ferrieres

6

0 references

Philippe Amouyel

object named as

P Amouyel

7

0 references

author name string

G Luc

1

1 reference

15 September 2017

J-P Empana

2

1 reference

15 September 2017

P Morange

3

1 reference

15 September 2017

I Juhan-Vague

4

1 reference

15 September 2017

D Arveiler

5

1 reference

15 September 2017

A Evans

8

1 reference

15 September 2017

F Kee

9

1 reference

15 September 2017

A Bingham

10

1 reference

15 September 2017

E Machez

11

1 reference

15 September 2017

P Ducimetiere

12

1 reference

15 September 2017

language of work or name

English

0 references

publication date

13 October 2009

1 reference

International Journal of Obesity

15 September 2017

published in

1 reference

15 September 2017

volume

34

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

118-126

1 reference

Body size and fat distribution as predictors of stroke among US men.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Risk factors for myocardial infarction in Brazil

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Adipokines: inflammation and the pleiotropic role of white adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Adiponectin and Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Adiponectin and Coronary Heart Disease: The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Plasma leptin and prognosis in patients with established coronary atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Adiponectin and risk of coronary heart disease in older men and women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Serum adiponectin and coronary heart disease risk in older Black and White Americans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Adiponectin reduces lipid accumulation in macrophage foam cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Adiponectin and protection against type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Association of plasma resistin levels with coronary heart disease in women.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Resistin is an inflammatory marker of atherosclerosis in humans.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Plasma resistin levels and risk of myocardial infarction and ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Role of resistin in obesity, insulin resistance and Type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Increased resistin gene and protein expression in human abdominal adipose tissue.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Relationships between human serum resistin, inflammatory markers and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Leptin and coronary heart disease risk: prospective case control study of British women.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.204

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.204

1 reference

15 September 2017

1 reference